Supernus Pharmaceuticals Stock Target Price and Analyst Consensus
| SUPN Stock | USD 31.26 0.09 0.29% |
The current analyst and expert consensus on Supernus Pharmaceuticals is Strong Buy, with 3 strong buy opinions. The current projected Supernus Pharmaceuticals target price consensus is 42.80 with 5 analyst opinions. Check out Macroaxis Advice on Supernus Pharmaceuticals to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. To learn how to invest in Supernus Stock, please use our How to Invest in Supernus Pharmaceuticals guide.The most common way Supernus Pharmaceuticals analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Supernus Pharmaceuticals executives and customers to further validate their buy or sell advice. Note, the total number of analysts currently providing their opinion is not significant to determine adequate consensus on Supernus Pharmaceuticals. We strongly encourage you to use your own analysis of Supernus Pharmaceuticals to validate this buy or sell advice. Supernus Pharmaceuticals buy-or-sell recommendation module provides average expert sentiment on the projected Supernus Pharmaceuticals target price to derive its highest and lowest estimates based on projected price volatility of 2.6601.
Lowest Forecast 38.95 | Highest Forecast 47.51 | Target Price 42.8 |
Supernus |
It's important to approach Supernus Pharmaceuticals' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Supernus Pharmaceuticals Target Price Consensus
Supernus target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Supernus Pharmaceuticals' target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 5 | Strong Buy |
Most Supernus analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Supernus stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Supernus Pharmaceuticals, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationSupernus Pharmaceuticals Target Price Projection
Supernus Pharmaceuticals' current and average target prices are 31.26 and 42.80, respectively. The current price of Supernus Pharmaceuticals is the price at which Supernus Pharmaceuticals is currently trading. On the other hand, Supernus Pharmaceuticals' target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
Supernus Pharmaceuticals Market Quote on 15th of March 2025
Target Price
Analyst Consensus On Supernus Pharmaceuticals Target Price
Supernus Pharmaceuticals Analyst Ratings
Supernus Pharmaceuticals' analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Supernus Pharmaceuticals stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Supernus Pharmaceuticals' financials, market performance, and future outlook by experienced professionals. Supernus Pharmaceuticals' historical ratings below, therefore, can serve as a valuable tool for investors.Analyst Consensus Breakdown
Average Consensus Estimates
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Supernus Pharmaceuticals price targets
Supernus Pharmaceuticals' stock target price is an estimate of its future price, usually made by analysts. Using Supernus Pharmaceuticals' target price to determine if it is a suitable investment can be done through the following steps:- Look at Supernus Pharmaceuticals' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Supernus Pharmaceuticals' stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Supernus Pharmaceuticals Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Supernus Pharmaceuticals is a key component of Supernus Pharmaceuticals valuation and have some predictive power on the future returns of a Supernus Pharmaceuticals.Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Warren Buffett Holdings Invested few shares | |
 | Artificial Intelligence Invested few shares | |
 | Video Games Invested few shares | |
 | Macroaxis Index Invested few shares | |
 | Automobiles and Trucks Invested over 60 shares | |
 | Investor Favorites Invested few shares | |
 | SRI Sustainable Growth Invested over 40 shares | |
 | Apparel Invested over 40 shares | |
 | Casinos Sold over 90 shares | |
 | Utilities Invested over 90 shares | |
Check out Macroaxis Advice on Supernus Pharmaceuticals to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. To learn how to invest in Supernus Stock, please use our How to Invest in Supernus Pharmaceuticals guide.You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.